| | 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-|3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- 基本信息 更多信息 |
| 中文名称: | 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- | | 中文同义词: | (S)-N-(3-(1-((6-(3,4-二甲氧基苯基)吡嗪-2-基)氨基)乙基)苯基)-5-甲基烟酰胺;化合物SERALUTINIB;塞拉替尼 | | 英文名称: | 3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- | | 英文同义词: | GB002;PK-10571;Seralutinib;3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-;Seralutinib (GB002);Seralutinib (PK-10571;(S)-N-(3-(1-((6-(3,4-Dimethoxyphenyl)pyrazin-2-yl)amino)ethyl)phenyl)-5-methylnicotinamide;PK 10571,Seralutinib,inhibit,arterial,PDGFR,PK10571,PK-10571,PAH,Pulmonary,hypertension,GB 002,GB-002,Inhibitor,Platelet-derived growth factor receptor | | CAS号: | 1619931-27-9 | | 分子式: | C27H27N5O3 | | 分子量: | 469.54 | | EINECS号: | | ![3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-|3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-](/CAS/20210111/GIF/1619931-27-9.gif) |
|
| 按国家浏览3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl-国外供应商 |
中国供应商 |
|
3-Pyridinecarboxamide, N-[3-[(1S)-1-[[6-(3,4-dimethoxyphenyl)-2-pyrazinyl]amino]ethyl]phenyl]-5-methyl- 推荐供应商 |
|
|
建议您优先选择企业会员,我们对企业会员产品有严格审核。 |
|
1
|